Bradykinin is produced through the enzymatic action of kallikreins on kininogen substrates. This process typically occurs in response to inflammatory stimuli, tissue injury, or allergic reactions. The peptide is rapidly degraded by kininases, such as angiotensin-converting enzyme (ACE), which highlights its short-lived nature in the bloodstream.
